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Introduction
Age-related declines in muscle strength characterise 
sarcopenia which is thought to explain many facets of 
morbidity in older people including increased falls and 
fracture risk1. Due to difficulties in objectively measuring 
muscle strength outside a laboratory setting, clinical 
definitions of sarcopenia are often based upon the functional 
consequences of impaired muscle strength on physical 
performance, with differing definitions proposed1,2. For 
example, gait speed, chair-rise time and balance all predict 
falls3,4 and, combined into the validated and well established 
composite short physical performance battery (SPPB)5, can 
identify individuals with sarcopenia6.
Upper-limb grip strength is widely used in clinical studies 
of older people as a measure of muscle strength (defined as 
the exertion of force to overcome resistance), and relates not 
only to functional measures like the SPPB7, but to a range 
of clinical sequelae including falls and fractures8-10. Lower-
limb muscle strength, which potentially has a more direct 
relationship to falls and fractures, is generally only measured 
as part of research studies. Jumping mechanography (JM), 
which unlike dynamometers for testing isometric muscle 
strength, can be used outside of a laboratory setting, and has 
been successfully used in child and adolescent research11,12; 
however, relatively few studies have examined this method 
in older adults13-15. In one recent US study, substantial age-
related changes were observed in lower-limb muscle power, 
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assessed by JM, which occurred earlier than deficits in grip 
strength or functional measures, suggesting lower-limb 
power may represent an important research, and possibly 
clinical, tool for detecting early deficits in muscle function16. 
This study detected weak positive relationships between 
lower-limb muscle power and grip strength (r=0.34) and 
SPPB (r=0.27), consistent with the suggestion that JM can 
detect early changes of sarcopenia.
JM calculates peak power as the product of force and 
velocity15,17, typically measured during standing two-legged 
countermovement jumps. JM also measures peak force 
directly through the force platform in Newtons, ideally during 
multiple one-legged hopping because peak forces are typically 
greater during one-legged serial hopping than either two-
legged serial hopping or countermovement or squat jumps18. 
Whilst peak power is thought to reflect muscle activity at 
the hip, knee and calf, peak force reflects additional joint 
bio-mechanics and tensile tendon properties (principally the 
Achilles). Hence, peak muscle power is strongly determined 
by muscle conditioning, whereas additional factors, such 
as tendon elasticity which may remain more constant over 
the life-course, influence muscle force. This may explain 
Figure 1. Flow chart explaining origin of study population and of jumping mechanography data collection.
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why peak lower-limb muscle power declines with age to a 
greater extent than muscle force19. Consequently, the more 
demanding one-legged serial hopping component of JM, 
required for assessing peak force, may provide minimal 
additional information regarding detection of early age-
related sarcopenia. Muscle weakness, principally assessed 
as strength, is a well-established risk factor for incident and 
recurrent falls20; lower limb muscle power assessed by JM 
has been associated with self-reported falls in one cross-
sectional study of older women21. Data linking measured 
muscle power and force to fractures however, are limited. 
Isometric lower limb muscle strength predicted incident 
fractures in one small Finnish cohort22, and lower limb muscle 
power (measured using the Nottingham power rig) predicted 
incident hip fractures in a large population of older men, but 
not after adjustment for bone density23.
We aimed to examine the feasibility and acceptability of 
evaluating components of sarcopenia based upon direct 
measurement of lower-limb muscle function by JM, in a 
community-based population of older women. In addition, 
to determine whether JM detects distinct aspects of muscle 
function compared to more established measures, we aimed 
to confirm that directly measured lower-limb muscle power 
and force only show a limited relationship with grip strength 
and SPPB. Finally, we aimed to extend previous observations 
suggesting peak lower-limb muscle power measured by JM 
can detect early sarcopenia, by examining the contribution 
made by peak muscle force to traditional measures of muscle 
function, namely grip strength and SPPB.
Materials and methods
Study participants
The VIBE (Vertical Impacts in Bone in the Elderly) study is a 
UK-based research program investigating the role of physical 
activity on musculoskeletal health in older adults with 
ranging functional capabilities24. This cross-sectional study, 
performed in 2015, re-recruited participants from an earlier 
population-based cohort study (Cohort for Skeletal Health in 
Bristol and Avon; COSHIBA) (Figure 1). The original COSHIBA 
participants (n=3200) were all female, born 1 January 
1927-31 December 1942 and recruited through Bristol and 
Avon general practitioner registries during 2007-2009, 
with no exclusion criteria25,26. Of 1286 who had previously 
consented to contact regarding future studies, 1064 (83%) 
were still alive and resident within Bristol/Avon in 2015 and 
were invited to participate in the VIBE study, of whom 463 
(43.5%) attended for assessment (invited alphabetically 
until appointments full).
Consenting participants attended our research clinic 
throughout 2015; physical function and musculoskeletal 
assessments were performed by fully trained staff working to 
standard operating procedures. All participants were eligible 
for physical function testing (i.e. SPPB and grip strength 
detailed below). After functional assessments, paper-based 
questionnaires provided demographic, socio-demographic, 
self-rated health and lifestyle data, and medical history 
(determining co-morbidities). Written informed consent was 
provided in line with the Declaration of Helsinki27. The study 
was approved by the Southwest Frenchay Research Ethics 
Committee (REC:14/SW/0138).
The short performance physical battery (SPPB)
The SPPB, used for pre-screening prior to JM (see below), 
was scored using standard methodology28; 3 components 
(i) gait speed: best of two 4-metre timed walks at normal 
pace, (ii) chair-rise time: 5 timed chair-rises performed 
as fast as possible (N.B. without use of upper limbs to rise 
from the chair), and (iii) tandem balance: stands held for 
maximum of 10 seconds with feet side-by-side, semi-tandem 
and then tandem. The time to perform each component 
was categorised, allocated a score; these 3 scores were 
summed to generate an overall SPPB score (minimum=zero, 
maximum=12)29.
Jumping mechanography (JM)
We used a 1 m2 Leonardo Mechanograph Ground Reaction 
Force platform (weight 60 kg, area 1 m2 and height 7 cm) 
which consists of two plates with eight sensors underneath 
each corner which detect a voltage proportional to applied 
force (Figure S1). Sensor recordings are used to derive test-
specific performance calculations using Leonardo software 
(version 4.2, Novotec Medical, Pforxheim, Germany). All 
staff completed standard training from Novotec Medical13. 
All participants scoring SPPB≥6 were eligible (i.e. physically 
Supplementary Figure S1. Leonardo Mechanograph 
Ground Reaction Force platform used for jumping and 
hopping assessments in the VIBE Study. Here two-legged 
countermovement jump (2LJ) is demonstrated.
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capable and safe to jump) and, if consenting, proceeded 
with jumping assessments. Vertebral osteoporosis was not 
considered a contraindication to JM. If participants expressed 
anxiety about their balance during the assessment, additional 
safety measures were considered, namely a) having an extra 
staff member present, and b) the staff member positioning 
themselves in front with arms out-stretched and forefingers 
pointing toward the participant to give reassurance (without 
adding any upward propulsion). 
Participant footwear was checked for suitability (flat soft 
soles; no heels) and removed if unsuitable. Prior to each 
assessment, the platform was calibrated (zero adjustment) 
and basic data input, e.g. age, gender, height (measured by 
calibrated Harpenden stadiometer). Body mass index (BMI) 
was calculated as weight (kilograms)/height (square metres). 
Clinic workers demonstrated and gave verbal instructions on 
how to perform a 2-legged countermovement jump (2LJ) 
and one-legged hops (1LH). If necessary they stood beside 
the participant to assist with balance on landing. Participants 
could use their arms in any way that was comfortable and 
standard instructions were provided: “I would like you to 
stand as still as you can please. When I instruct you to do 
so, I would like you to jump once as high as possible using 
both legs. Land on your forefoot and then stand as still as 
possible on both feet”. For the single-legged hopping test 
(1LH), participants were encouraged to start with their most 
comfortable or dominant leg and attempt 6-8 hops with 
the standard instructions: “When I instruct you to begin, I 
would like you to hop on your forefoot, without landing on 
your heels using a stiff knee and follow the instructions as I 
provide them. Stand still to start on both legs”. 2LJ and 1LH 
were each attempted three times, unless there was an error, 
in which case a maximum of four attempts was allowed. 1LH 
was only attempted if 2LJ could be performed. Participants 
remained standing between jumps/hops and recommenced 
when they were recovered and ready. Reasons were recorded 
if jumps/hops were not performed (unable/equipment failure 
(n=15)/other) (Figure 1). Clinic workers recorded adverse 
events. Peak power (kW) from the maximal valid 2LJ and 
the maximal peak force (kN) from all 1LH were extracted. 
Isotonic peak power and force relative to body weight were 
derived using body mass measured using calibrated Tanita 
weighing scales (Tanita UK Ltd.), prior to JM assessment. 
Peak weight-adjusted maximum power (W/kg) and force (N/
kg) were used in analyses.
Supplementary Table S1. Characteristics of women recruited into the original COSHIBA study (2007-09) who did and did not participate in 
the subsequent 2015 VIBE study.
Historic COSHIBA population who did not 
participate in the VIBE study
All VIBE study participants
n mean (SD) n mean (SD) p value
Age 2737 73.2 (4.3) 463 69.7 (2.9) <0.001
Height (cm) 2433 160.0 (6.5) 422 161.0 (6.4) 0.004
Weight (kg) 2589 69.6 (13.4) 452 68.6 (12.0) 0.167
n % n  %  p value
Smoker    0.015
Current 219 8.1 23 5.0
Past 1058 39.2 165 36.2
Never 1421 52.7 268 58.8
Weekly alcohol consumption     <0.001
None 1219 45.2 155 33.7
Few glasses per week 1153 42.7 235 51.1
1 drink daily 236 8.7 48 10.4
>1 drink daily 82 3.0 20 4.4
Don’t know/ can’t remember 10 0.4 2 0.4
Educational level     <0.001
School education until 16 years old 1485 56.3 214 47.3
School education until 18 years old 247 9.4 77 17.0
Apprenticeship 613 23.3 98 21.7
University degree 116 4.4 46 10.2
Other 50 1.9 6 1.3 
Don’t know/ can’t remember 126 4.8 11 2.4
P; p value for difference. SD; Standard Deviation, COSHIBA; Cohort for Skeletal Health in Bristol and Avon, VIBE; Vertical Impacts in Bone 
in the Elderly. Data recorded at COSHIBA baseline.
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Acceptability of jumping mechanography
To assess acceptability of JM in older people, participants 
were asked two questions upon completion of their jump 
assessment; 1) “how frequently have you performed these 
types of movements (jumping and hopping) in the past 12 
months?” (options: never/rarely/every once in a while/often/
very often), and 2) “how comfortable did you feel carrying 
out the movements” (very uncomfortable/uncomfortable/
unsure/comfortable/very comfortable). 
Upper-limb grip strength
Isometric grip strength was measured by JAMAR 
electronic handgrip dynamometery30, whilst standing with 
one arm fully extended beside the body, with a stiff wrist and 
a 2 cm gap between arm and body. Standardised participant 
instructions based upon the Southampton approach ensured 
comparability in grip strength assessments31; maximal grip 
strength was taken from six attempts on alternating sides 
with the instruction “I want you to squeeze as hard as you 
Table 1. Characteristics of 463 women who attended the VIBE study clinics who were and were not eligible/able to produce valid jumping 
and/or hopping measurements by jumping mechanography.
Participants attending VIBE study clinic 
eligible and able to produce valid jump/
hop data 
Participants attending VIBE 
study clinic either ineligible or 
unable to produce valid jump/
hop data4
 N % or mean ±SD N % or mean ±SD P value
Total 300 65 163 35  
Age 300 76.4±2.6 163 77.7±3.6 <0.01
Height (cms) 300 159.4±6.0 163 157.4±6.1 <0.01
Weight (kgs) 300 66.6±10.5 163 72.7±14.6 <0.01
BMI (kg/m2) 300 26.2±.83 163 29.3±5.70 <0.01
Self-rated health     <0.01
     Very good 92 31.1% 20 12.4%  
      Good 174 58.8% 78 48.5%  
      Fair 28 9.5% 56 34.8%  
      Poor 2 0.7% 7 4.4%  
      Very poor 0 0% 0 0%  
Co-morbidities     <0.01
      No co-morbidities 97 32.3% 19 11.7%  
      At least one co-morbidity1 203 67.7% 144 88.3%  
Current smoker 12 4.0% 8 4.9% 0.66
Consumed alcohol in the past year 257 86.5% 109 66.9% <0.01
At least one fall in the past year 77 26.3% 76 47.8% <0.01
Taking vitamin D and/or calcium 
supplements
90 30.6% 82 51.9% <0.01
Lower-limb JM Maximum Power (W/kg)2 300 20.5±5.1    
Lower-limb JM Maximum Force (N/kg)3 300 20.2±4.7    
Upper limb grip strength (kg) 300 21.6±4.9 158 19.3±5.6 <0.01
SPPB score (max of 12 points) 300 10.6±1.4 155 8.3±2.8 <0.01
     Gait speed time (secs) 300 4.01±0.9 146 5.3±2.2 <0.01
     Chair-rise time (secs) 299 12.9±4.2 127 15.5±6.2 <0.01
      Tandem balance held for the maximum 
of 10 seconds
263 87.7% 88 54.0% <0.01
P=p value for difference. BMI=Body Mass Index. SD=Standard Deviation. SPPB=Short Physical Performance Battery, JM=Jumping 
Mechanography. 
1At least one of the following: Chronic non-specific lung disease(13%), cardiovascular disease (10%), peripheral arterial disease (1%), 
Diabetes mellitus (5%), Stroke (3%), Cancer (21%), Osteoporosis (11%), Arthritis (37%), Chronic liver/kidney disease (2%), Thyroid 
condition (10%), Coeliac disease(1%). 
2Maximum power generated from two legged jump, relative to weight. 
3Maximum force generated from one footed hop, relative to weight. 
4Full details shown in Figure 1.
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can for as long as you can until I say stop. Squeeze, squeeze, 
squeeze, stop”. Grip strength was recorded to the nearest 0.1 
kg; if not performed, reasons were recorded.
Statistical analyses
Descriptive statistics were compared between 
participants able to perform 2LJ and 1LH and the remaining 
clinic attendees. Data distributions were transformed 
where necessary. Continuous variables were summarised 
as mean (standard deviation:SD) and categorical variables 
as counts (percentages). Co-morbidities, identified by 
questionnaire, were deemed a priori to have a potential 
impact on musculoskeletal health.
In analysing the relationship between age, muscle 
power, force and grip strength, analyses were restricted to 
participants with at least one valid jump and hop measurement. 
Multivariable linear regression models examined associations 
between weight-adjusted peak power and force with grip 
strength, overall SPPB score, gait speed and chair-rise 
time. Multivariable logistic regression models examined 
associations between power/force and (binary) tandem 
balance (87.7% could balance for the maximum 10secs). 
Adjusted analyses included the a priori confounders age, 
height and co-morbidities (co-morbidities vs.≥1 co-morbidity).
To assess the relative contributions of power and force 
Table 2. Comfort performing JM and frequency over the past 12 months of jumping/hopping activity amongst study participants according 
to co-morbidities.
All women Women with Arthritis
Women with Lung 
disease
Women with  ≥1 co-
morbidity
 N=279 n (%) n (%) n (%) n (%)
Comfort performing jumps/hops
 Very uncomfortable/uncomfortable 38 (13.6) 12 (11.3) 7 (20.0) 26 (13.5)
 Not sure 64 (22.9) 30 (28.3) 8 (22.9) 48 (25.0)
 Comfortable 155 (55.6) 56 (52.8) 18 (51.4) 106 (55.2)
 Very comfortable 22 (7.9) 8 (7.6) 2 (5.7) 12 (6.3)
Frequency of jump/hop activity in 
past 12 months
   
 Never 92 (33.0) 36 (34.0) 13 (37.1) 70 (36.5)
 Rarely 76 (27.2) 31 (29.3) 8 (22.9) 59 (30.7)
 Every once in a while 63 (22.6) 21 (19.8) 11 (31.4) 36 (18.8)
 Often 37 (13.3) 14 (13.2) 2 (5.7) 21 (10.9)
 Very often 11 (3.9) 4 (3.8) 1 (2.9) 6 (3.1)
JM: Jumping mechanography.
Table 3. Associations between comfort performing JM and past 12-month frequency of jumping/hopping with peak power and force.
N=279 N (%)
Power1 Force1
β 95% CI P value β 95% CI P value
Comfort of jump/hop movements
Very uncomfortable/uncomfortable 
(ref)
38 (13.6) - - <0.01 - - <0.01
Not sure 64 (22.9) -0.04 -0.21, 0.12 -0.16 -0.49, 0.18
Comfortable 155 (55.6) 0.07 -0.08, 0.21 0.07 -0.23, 0.37
Very comfortable 22 (7.9) 0.36 0.15, 0.58 0.21 -0.23, 0.65
Frequency of jump/hop movements
Never (ref) 92 (33.0) - - <0.01 - - <0.01
Rarely 76 (27.2) 0.11 -0.02, 0.23 0.08 -0.18, 0.33
Every once in a while 63 (22.6) 0.23 0.09, 0.36 0.22 -0.05, 0.49
Very often/often 48 (17.2) 0.15 0.01, 0.30 0.37 0.07, 0.66
P; p value for trend. CI; Confidence Interval. JM: Jumping mechanography. SD: Standard Deviation. 
1Force and power relative to weight. Standardized beta coefficients represent SD difference in outcome for each category of exposure 
compared with the reference category (ref).
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in predicting grip strength and SPPB components, r2 
values (logistic regression pseudo r2) and a fit statistic 
(AIC=Akaike information criterion32) were calculated from 
adjusted regression models, with each exposure assessed 
independently and in combination. The AIC statistic is used 
to compare the ‘goodness of fit’ between similar models and 
penalizes for additional variables, thus identifying the model 
with ‘best fit’, with a minimum number of parameters. Lower 
AIC values indicate better ‘goodness of fit’. 
All continuous exposure and outcome variables were 
standardized for regression analyses. Standardised beta 
coefficients, with 95% confidence intervals (CI), are 
presented representing a SD change in outcome per SD 
change in exposure. Data were collected using a secure 
online database (REDcap) with inbuilt data checks; analyses 
performed using Stata 13.1.
Results
Participant characteristics
Of 1064 women invited, 463(44%) attended the VIBE 
study clinic; they were mean 77 years old with BMI 26.5 kg/
m2 (Figure 1). From inception of the cohort in 2007-2009, 
those subsequently attending the 2015 VIBE clinic were 
younger, less likely to smoke, but more likely to consume 
alcohol, with higher qualification attainment and lower BMI, 
than those who did not attend (Table S1).
Feasibility of jumping mechanography 
Of 463 women attending the VIBE clinic, 37(8%) with 
SPPB<6 were ineligible to perform JM and 53(11%) declined, 
often due to fear of jumping on a hip/knee joint replacement; of 
those eligible to perform JM, 61(74%) with a joint replacement 
consented vs. 311(91%) without (p<0.01). Of the remaining 
373 individuals, 359(96%) were able to perform at least 
one valid 2LJ (Figure S1), and 300(80%) also completed at 
least one valid 1LH. 14 participants required assistance with 
balance on landing from the clinic worker stood beside the 
jump platform. No adverse events occurred during JM for any 
participant. The 300 who successfully completed both JM 
measurements were all community-dwelling women (97% 
white British) with mean age 76 years (range: 71-87) and BMI 
26.2 kg/m2 (range: 16.5-41.0) (Table 1). Self-rated health 
was deemed good or very good by 90%; 68% self-reported 
≥1 co-morbidity, the most prevalent being arthritis (37%) 
and cancer (21%). The 163 who attended the VIBE clinics but 
were ineligible, unwilling or unable to generate JM data were 
generally older (mean age 78), had higher mean BMI (29.3 
kg/m2), lower self-rated health (61% good or very good) and 
scored lower on physical function tests. 
Acceptability of jumping mechanography
Information about the comfort of performing JM was 
available in 279(93%) participants. The majority (86%) 
did not find the assessment uncomfortable; 64% even 
reporting JM to be comfortable or very comfortable (Table 
2). The assessment was similarly acceptable for women with 
self-reported co-morbidities; JM was comfortable or very 
comfortable in 62% with ≥1 co-morbidity, 60% with arthritis 
and 57% with lung disease. Discomfort was not associated 
with self-reported hip and/or knee replacement. Of the 
300 women completing both JM components, most (83%) 
reported they had not often performed jumping and hopping 
movements over the previous twelve months.
Reported comfort while performing JM was related 
to JM performance, with positive associations observed 
with both power and force (test for trend p<0.01) (Table 
3). A similar relationship was also observed with reported 
frequency of jumping and hopping over the previous year. 
Figure 2. Scatter plots with linear regression lines and 95% confidence intervals, and correlation coefficients shown to illustrate the 
relationships between muscle power (A), force (B), and grip strength (C) and age within our study population.
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Power and force vs. age
Whilst power was lower with age (unadjusted standardized 
β [95% CI] -0.19 [-0.25, -0.12], p<0.01), force was not (0.07 
[-0.31, 0.45], p=0.71). Grip strength was inversely associated 
with age (-0.15 [-0.26, -0.03], p=0.01) (Figure 2).
Power and force vs. SPPB and grip strength
Power and force were both positively associated with 
SPPB, with the stronger association seen for power 
(unadjusted standardized β 0.41 [0.10, 0.72], p<0.01) (Table 
S2). Power was also the stronger predictor of faster gait 
speed (β -0.47 [-0.22, -0.72], p<0.01), quicker chair-rise 
time (β -0.46 [-0.18, -0.74], p<0.01) and increased odds of 
holding the tandem balance for 10 seconds (OR 12.4 [3.43, 
45.1], p<0.01). Whilst power showed a moderate association 
with grip strength (β 0.24 [0.10, 0.38], p<0.01), force did 
not (Figure S2). After adjustment for age, height and co-
morbidities, results were largely unchanged. After accounting 
for age, height and co-morbidities, power and force accounted 
for similar proportions of variance in SPPB (r2=0.08, 0.10 
respectively), and combined explained 13% (Table 4). Power 
demonstrated the higher r2 and lowest AIC for gait speed 
(r2=0.12) and tandem balance models (pseudo r2=0.09), 
whilst force provided the best ‘goodness of fit’ for chair-rise 
time (r2=0.09). Power accounted for 17% of variance in grip 
strength, which was unchanged by the addition of force.
Discussion
Feasibility and acceptability of JM
We aimed to assess the feasibility and acceptability of 
JM in community-dwelling older women. We used the SPPB 
to screen out individuals in whom the risk of falls and other 
adverse events was deemed excessive, which only excluded 
a small proportion from assessment (8%). This strategy was 
Supplementary Table S2. Associations between jumping mechanography peak power and force with grip strength, the SPPB and its three 
components1.
Grip Strength SPPB score Gait speed Chair-rise time Tandem balance
Exposures Adjustment β
95% 
CI
P β
95% 
CI
P β
95% 
CI
P β
95% 
CI
P OR
95% 
CI
P
Power3
 
Unadjusted 0.24
0.10, 
0.38
<0.01 0.41
0.10, 
0.72
0.01 -0.47
-0.72, 
-0.22
<0.01 -0.46
-0.74, 
-0.18
<0.01 12.44
3.43, 
45.1
<0.01
Adjusted 2 0.21
0.06, 
0.35
<0.01 0.39
0.08, 
0.70
0.01 -0.44
-0.70, 
-0.18
<0.01 -0.42
-0.70, 
-0.13
<0.01 15.16
3.99, 
57.6
<0.01
Force3
 
Unadjusted 0.01
-0.05, 
0.07
0.68 0.22
0.11, 
0.34
<0.01 -0.13
-0.23, 
-0.03
0.01 -0.24
-0.38, 
-0.11
<0.01 1.79
1.08, 
2.96
0.02
Adjusted 2 0.04
-0.01, 
0.09
0.14 0.22
0.12, 
0.32
<0.01 -0.13
-0.21, 
-0.05
<0.01 -0.23
-0.34, 
-0.11
<0.01 1.87
1.12, 
3.13
0.02
P; p value. CI; Confidence Interval. OR; Odds Ratio. SD: Standard Deviation. 
n=300 for analyses with SPPB score, gait speed & tandem balance. n=299 for chair-rise time. 
1All continuous exposure and outcome variables standardized. Standardized beta coefficients represent SD change in outcome per SD change in exposure. 
2Adjusted for age, height and comorbidities. 
3power and force relative to weight.
Table 4. Contributions of peak power and force to grip strength and 
each component of the SPPB.
Outcome Model₁ R2 AIC
Grip 
strength 
(kg)
Base model 0.134 349.61
Base model +power 0.165 340.87
Base model +force 0.139 349.95
Base model +power 
+force
0.166 342.58
SPPB score
Base model 0.021 588.05
Base model +power 0.076 572.59
Base model +force 0.100 564.67
Base model +power 
+force
0.130 556.52
Gait speed 
(metres/
second)
Base model 0.030 515.45
Base model +power 0.118 488.77
Base model +force 0.067 505.78
Base model +power 
+force
0.134 485.40
Chair-
rise time 
(seconds)
Base model 0.032 723.58
Base model +power 0.071 713.19
Base model +force 0.086 708.43
Base model +power 
+force
0.108 703.15
Tandem 
balance₂
Base model 0.008 230.31
Base model +power 0.089 214.12
Base model +force 0.036 226.00
Base model +power 
+force
0.093 215.34
Base model is adjusted for age, height and co-morbidities. 
AIC=Akaike information criterion. 
₁ Force and power relative to weight. 
₂ Binary outcome, includes pseudo r2 results. 
NB Power and force were weakly correlated r=0.24. 
N=300 for all except chair-rise time (n=299).
254http://www.ismni.org
K. Hannam et al.: Acceptability of jumping mechanography
effective, since no participant undergoing JM experienced an 
adverse event. The safety of performing JM in older individuals, 
providing suitable precautions are in place, is supported 
by two smaller US studies: no injuries were reported in 60 
adults, aged 55-75 years, where JM was performed provided 
a physician had given medical clearance33, nor in a further 40 
men and women aged >60 years34.
Unlike previous studies assessing JM safety in older 
people, we did not exclude those with co-morbidities in order 
to maximize generalisability of our findings; in fact, two 
thirds had at least one co-morbidity. Ours is the first study 
to seek participant opinion regarding JM acceptability. Whilst 
most women reported infrequently performing jumping and 
hopping movements day-to-day, the majority felt comfortable 
with our JM assessment, with similar acceptability amongst 
those with co-morbidities, including arthritis and lung disease. 
That said, we observed a positive relationship between 
comfort levels while performing JM, and peak power and force 
achieved. Therefore, in those older individuals able to perform 
JM despite some discomfort, results may be artefactually 
reduced due to technical difficulties in test performance.
Peak muscle force, measured by one-footed hopping, 
is more physically demanding than two-legged jumping 
measuring peak muscle power, and is less commonly used; 
although 84% of those able to perform two-legged jumps 
were also able to perform one-footed hopping. One previous 
JM study used a 2-legged jump to calculate force in 30 
women and men aged 80+19, which may be a more feasible 
approach in older individuals with a tendency towards balance 
impairment. Furthermore, to what extent peak muscle force 
shows equivalent age-related declines to those previously 
reported for muscle power16, and reflects early sarcopenic 
changes, is currently unclear. In addition, muscle force may 
be less helpful clinically as, despite the relatively narrow age 
range, peak power was inversely related to age whilst peak 
force was not.
Relationships between peak power, peak force and other 
measures of muscle function
The extent to which peak muscle power and force show 
differing relationships with functional tests may also provide a 
rationale for their added clinical utility. Peak power principally 
predicted grip strength; peak force had no additional 
explanatory value. However, peak muscle power and force 
together explained a greater proportion of variance in SPPB 
than either did alone, suggesting both measures reflect 
different components of muscle function in older women. Our 
finding that peak muscle power predicts SPPB is consistent 
with studies in older US16 and Italian35 populations; ours is the 
first UK study. However, we are not aware of previous studies 
assessing the differential contributions of lower-limb muscle 
power and force to SPPB. 
Regarding individual SPPB components, we found peak 
power best explained gait speed and tandem balance, whilst 
peak force best explained chair-rise time. Power, a function of 
force and velocity, perhaps unsurprisingly best explained gait 
speed; however, this contrasts with only weak correlations 
between jumping power and gait speed (r=0.10) previously 
reported in older community-dwelling US adults16. We further 
identified peak power as the strongest predictor of tandem 
balance; power, thought to reflect lower-limb muscle activity, 
can de-condition with age. Power training improves balance 
in healthy older Australians36. We are not aware of previous 
reports linking peak muscle force to chair-rise time; however, 
the latter has been associated with the related measure of 
rate of force development37,38.
Our observation that peak muscle power and force 
are related to widely used measures of muscle function, 
namely SPPB, including the individual components thereof, 
supports the clinical relevance of measures obtained from 
JM. Furthermore, these measures relate to other health 
outcomes; peak power was associated cross-sectionally with 
Supplementary Figure S2. Scatter plots with linear regression lines with 95% confidence intervals, and correlation coefficients shown 
to illustrate the relationships between muscle power (A) and force (B), with grip strength.
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falls amongst women aged 60-8521,39. In men and women 
(mean age 56), peak power was positively related to hip bone 
density, whereas peak force was related to bone size40. JM 
has the advantage of precisely measuring specific elements 
of muscle function, whereas the SPPB is a composite measure 
of task-specific neuro-muscular function. This precision may 
be of clinical relevance, providing greater sensitivity with 
which to detect early changes associated with sarcopenia.
Peak lower-limb muscle power and force, together 
explaining only 13% of variance in SPPB, suggests that 
SPPB reflects components of physical function which are 
in part independent of lower-limb muscle power and force. 
This is consistent with previous observations that lower-limb 
muscle power and jumping height, measured by JM, show 
earlier age-related changes compared to SPPB16. Therefore, 
whilst JM lower-limb muscle function measures are related 
to clinical and functional outcomes such as SPPB, they may 
provide additional information regarding early sarcopenia. 
The same conclusion applies to grip strength, for which JM 
only explained 17% of variance. Whilst peak muscle power 
has been reported to show more rapid age-related changes 
compared to grip strength16, in our study, age-related 
associations with these two parameters were similar. 
Limitations
Despite being the largest study of its kind to date, 
there are several limitations. Analysis of only women 
limits generalisability of findings. Our final study 
population represents a small proportion of the original 
historic population-based COSHIBA cohort and reduces 
generalisability of results; participants were younger and 
better educated than non-participants. Frailer, older women 
unable to consent due to cognitive impairment were excluded. 
Self-reported co-morbidities were subject to recall bias, 
hence we used non-specific terms such as ‘arthritis’; however, 
we expect any misclassification to be non-differential. Whilst 
our policy of using an SPPB<6 to screen out those at high falls 
risk was effective at avoiding adverse events, it does limit the 
utility of JM for all older people. However, as JM may be best 
placed to identify early sarcopenic changes in advance of 
other traditional tools, and as individuals with SPPB<6 are 
more likely to have established sarcopenia, this restriction in 
application in conjunction with the SPPB may be beneficial. 
Currently though, utility may be predominantly restricted by 
the cost of JM equipment (~15,000 euros). 
Conclusions
Our results suggest that jumping mechanography is a 
feasible, safe, and acceptable method for evaluating lower-
limb muscle function in the majority of community-dwelling 
older women (aged 71-87 years), using a pre-screening 
strategy of a SPPB≥6 threshold. In addition to measurement 
of peak power through two-legged jumps, peak force from 
one-legged hops is also feasible in the majority, and provides 
additional information regarding physical function, given its 
relationships with SPPB. Despite the strong associations of 
both peak muscle power and force with SPPB, these only 
explain a relatively small proportion of overall variance 
in SPPB, suggesting JM detects distinct components of 
physical function compared to those evaluated by more 
functional measures, possibly including those aspects 
affected in early sarcopenia. Further studies are justified to 
examine to what extent peak power and force, as measured 
by JM, have additional functional consequences not detected 
by conventional measures such as SPPB and grip strength, 
and/or provide useful prognostic information for selecting 
individuals for preventative measures such as exercise 
programmes.
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